Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2015 Elsevier Ltd.Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. This article examines strategies for the prevention and early diagnosis of CRC, and reviews the aetiology and risk factors for CRC. Preventative strategies involve improving modifiable risk factors through public health awareness. Patients known to be at higher risk of CRC development, such as those with a genetic predisposition or longstanding inflammatory bowel disease, should undergo endoscopic surveillance in order to detect early cancer or polyps. Population screening for CRC is now strongly established as an effective method for the early detection of CRC and prevention through polypectomy. Screening has been shown to improve the stage of disease at diagnosis and CRC-specific mortality. This article will highlight recent developments in the understanding of the serrated pathway for CRC development and discuss the clinical relevance of this in terms of cancer prevention, as well as exploring future directions for research into the prevention and early diagnosis of CRC.

Original publication




Journal article


Medicine (United Kingdom)

Publication Date